![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 9/04 | |
A61K 31/40 | |||
A61K 9/14 |
(11) | Number of the document | 2903690 |
(13) | Kind of document | T |
(96) | European patent application number | 13844343.7 |
Date of filing the European patent application | 2013-10-02 | |
(97) | Date of publication of the European application | 2015-08-12 |
(45) | Date of publication and mention of the grant of the patent | 2020-01-22 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/063096 |
Date | 2013-10-02 |
(87) | Number | WO 2014/055667 |
Date | 2014-04-10 |
(30) | Number | Date | Country code |
201261710489 P | 2012-10-05 | US | |
201213670355 | 2012-11-06 | US | |
201313914452 | 2013-06-10 | US |
(72) |
RAJEWSKI, Lian, G., US
RAJEWSKI, Roger, A., US
HEPPERT, Kathleen, US
HASLAM, John, L., US
BECKLOFF, Michael, C., US
SEGRAVE, Frank, US
MAURO, Robert, US
COLABUONO, Peter, US
|
(73) |
The University of Kansas,
245 Strong Hall 1450 Jayhawk Boulevard, Lawrence, KS 66045,
US
Silvergate Pharmaceuticals, Inc., 6251 Greenwood Plaza Blvd. Suite 101, Greenwood Village, CO 80111, US |
(54) | ENALAPRIL COMPOSITIONS |
ENALAPRIL COMPOSITIONS |